6919 fundamentals
CALIWAY BIOPHARMACEUTICALS CO LTD financial statements, including revenue, expenses, and profit
The total revenue of 6919 for the last quarter is 0.00 TWD, and it's 100.00% lower compared to the previous quarter. The net income of Q1 25 is -175.56 M TWD.
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: TWD
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
TTM